Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-06 @ 12:22 PM
Study NCT ID:
NCT03077451
Status:
COMPLETED
Last Update Posted:
2025-12-17
First Post:
2016-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-19
First Submit QC Date:
None
Study First Post Date:
2017-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-02
Results First Submit QC Date:
None
Results First Post Date:
2024-02-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED